Literature DB >> 31530689

An overview of the management of diabetes from pre-conception, during pregnancy and in the postnatal period.

Chloe Broughton1, Isy Douek2.   

Abstract

Diabetes is one of the most common medical conditions complicating pregnancy. Both pre-existing diabetes and gestational diabetes are associated with increased risks to the mother and fetus. These risks can be reduced by improving pre-conception and antenatal care. Pre-conception planning and care is important to ensure women are taking high dose folic acid, to optimise glucose control, to review medications and to screen for and manage any complications. All women with either pre-existing diabetes or gestational diabetes should be reviewed by the antenatal team every 1-2 weeks throughout pregnancy. This is to optimise glucose control and to monitor fetal growth and development. Women with diabetes in pregnancy should receive an individualised care plan for delivery. The exact timing of delivery will depend on maternal glucose control, fetal growth and any other complications. Women diagnosed with gestational diabetes in pregnancy are at high risk of developing both gestational diabetes and type 2 diabetes in the future. After delivery, they should be offered a fasting plasma glucose at 6 weeks or a glycated haemoglobin (HbA1c) at 13 weeks to ensure that the gestational diabetes has resolved and an annual HbA1c.
© 2019 Royal College of Physicians.

Entities:  

Keywords:  Gestational diabetes; antenatal; diabetes; intrapartum; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31530689      PMCID: PMC6771338          DOI: 10.7861/clinmed.2018-0288

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  9 in total

1.  Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.

Authors:  R Bell; S V Glinianaia; P W G Tennant; R W Bilous; J Rankin
Journal:  Diabetologia       Date:  2012-02-08       Impact factor: 10.122

2.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome.

Authors:  M E Griffin; M Coffey; H Johnson; P Scanlon; M Foley; J Stronge; N M O'Meara; R G Firth
Journal:  Diabet Med       Date:  2000-01       Impact factor: 4.359

Review 4.  Diabetic retinopathy in pregnancy: a review.

Authors:  Julie L Morrison; Lauren Ab Hodgson; Lyndell L Lim; Salmaan Al-Qureshi
Journal:  Clin Exp Ophthalmol       Date:  2016-05-17       Impact factor: 4.207

5.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17

6.  Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study.

Authors:  Helen R Murphy; Ruth Bell; Cher Cartwright; Paula Curnow; Michael Maresh; Margery Morgan; Catherine Sylvester; Bob Young; Nick Lewis-Barned
Journal:  Diabetologia       Date:  2017-06-08       Impact factor: 10.122

7.  The NHS long term plan.

Authors:  Hugh Alderwick; Jennifer Dixon
Journal:  BMJ       Date:  2019-01-07

8.  Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study.

Authors:  Peter W G Tennant; Svetlana V Glinianaia; Rudy W Bilous; Judith Rankin; Ruth Bell
Journal:  Diabetologia       Date:  2013-11-29       Impact factor: 10.122

9.  Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.

Authors:  Denice S Feig; Lois E Donovan; Rosa Corcoy; Kellie E Murphy; Stephanie A Amiel; Katharine F Hunt; Elizabeth Asztalos; Jon F R Barrett; J Johanna Sanchez; Alberto de Leiva; Moshe Hod; Lois Jovanovic; Erin Keely; Ruth McManus; Eileen K Hutton; Claire L Meek; Zoe A Stewart; Tim Wysocki; Robert O'Brien; Katrina Ruedy; Craig Kollman; George Tomlinson; Helen R Murphy
Journal:  Lancet       Date:  2017-09-15       Impact factor: 79.321

  9 in total
  3 in total

Review 1.  Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects.

Authors:  R D Wilson; D L O'Connor
Journal:  Prev Med Rep       Date:  2021-10-25

Review 2.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

Review 3.  Developmental Effects of (Pre-)Gestational Diabetes on Offspring: Systematic Screening Using Omics Approaches.

Authors:  Bachuki Shashikadze; Florian Flenkenthaler; Jan B Stöckl; Libera Valla; Simone Renner; Elisabeth Kemter; Eckhard Wolf; Thomas Fröhlich
Journal:  Genes (Basel)       Date:  2021-12-15       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.